Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Strong Buy
Analyst Rating
Strong Buy
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Neutral
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Buy
A
Syros Pharmaceuticals, Inc. Common Stock (SYRS)
Pharmaceutical Preparations
Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is mainly involved in the segments of pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.
35 CAMBRIDGE PARK DRIVE
CAMBRIDGE, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/30/2016
Market Cap
40,359,733
Shares Outstanding
26,010,000
Weighted SO
26,006,662
Total Employees
N/A
Upcoming Earnings
08/13/2024
Beta
1.5280
Last Div
0.0000
Range
1.48-8.17
Chg
-0.0200
Avg Vol
222866
Mkt Cap
40359733
Exch
NASDAQ
Country
US
Phone
617 744 1340
DCF Diff
1.5743
DCF
6.0743
Div Yield
0.0000
P/S
9.7299
EV Multiple
-0.1853
P/FV
-9.3351
Div Yield %
0.0000
P/E
-0.4507
PEG
-0.0210
Payout
0.0000
Current Ratio
3.4632
Quick Ratio
3.4632
Cash Ratio
3.2203
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
1747.5545
CCC
-1747.5545
Gross Margin
0.6239
Op Margin
-28.9243
Pretax Margin
-31.7170
Net Margin
-31.7170
Eff Tax Rate
-0.0599
ROA
-1.2328
ROE
-8.5334
ROCE
-1.4596
NI/EBT
1.0000
EBT/EBIT
1.0966
EBIT/Rev
-28.9243
Debt Ratio
0.4069
D/E
-6.8371
LT Debt/Cap
1.1837
Total Debt/Cap
1.1713
Int Coverage
2448.5306
CF/Debt
-2.5602
Equity Multi
-16.8013
Rec Turnover
0.0000
Pay Turnover
0.2089
Inv Turnover
0.0000
FA Turnover
0.2276
Asset Turnover
0.0389
OCF/Share
-2.8314
FCF/Share
-2.8324
Cash/Share
2.0108
OCF/Sales
-26.8052
FCF/OCF
1.0003
CF Coverage
-2.5602
ST Coverage
-44.5643
CapEx Coverage
-2926.0000
Div&CapEx Cov
-2926.0000
P/BV
-9.3351
P/B
-9.3351
P/S
9.7299
P/E
-0.4507
P/FCF
-0.3629
P/OCF
-0.5333
P/CF
-0.5333
PEG
-0.0210
P/S
9.7299
EV Multiple
-0.1853
P/FV
-9.3351
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
98.00K Shares Bought (69.58 %)
42.84K Shares Sold (30.42%)
3 - 6 Months
126.06K Shares Bought (41.88 %)
174.95K Shares Sold (58.12%)
6 - 9 Months
1.13M Shares Bought (78.71 %)
304.33K Shares Sold (21.29%)
9 - 12 Months
38.00K Shares Bought (70.32 %)
16.04K Shares Sold (29.68 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 893.00K | ▼ 508.00K | ▲ 5.70M | ▲ 7.80M | ▼ -5.47M | ▲ 386.00K | ▼ 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 770.00K | ▼ 279.00K | ▲ 334.00K |
Gross Profit | 893.00K | ▼ 508.00K | ▲ 5.70M | ▲ 7.80M | ▼ -6.24M | ▲ 107.00K | ▼ -334.00K |
Gross Profit Ratio | 1.00 | 1.00 | 1.00 | 1.00 | ▲ 1.14 | ▼ 0.28 | ▼ 0.00 |
Research And Development Expenses | 15.13M | ▼ 14.28M | ▲ 29.03M | ▼ 26.80M | ▲ 27.91M | ▼ 21.22M | ▲ 24.32M |
General And Administrative Expenses | 4.37M | ▲ 6.40M | ▼ 5.89M | ▲ 6.43M | ▲ 7.33M | ▼ 5.89M | ▲ 6.27M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 4.37M | ▲ 6.40M | ▼ 5.89M | ▲ 6.43M | ▲ 7.33M | ▼ 5.89M | ▲ 6.27M |
Other Expenses | 575.00K | ▼ 441.00K | ▼ 0.00 | 0.00 | ▲ 9.51M | ▼ 135.00K | ▼ 0.00 |
Operating Expenses | 19.50M | ▲ 20.68M | ▲ 34.92M | ▼ 33.23M | ▲ 35.24M | ▼ 27.11M | ▲ 30.59M |
Cost And Expenses | 19.50M | ▲ 20.68M | ▲ 34.92M | ▼ 33.23M | ▲ 35.24M | ▼ 27.39M | ▲ 30.92M |
Interest Income | 0.00 | 0.00 | 0.00 | ▲ 31.00K | ▲ 1.59M | ▼ 1.28M | ▲ 1.55M |
Interest Expense | 0.00 | 0.00 | ▼ -1.79M | ▲ 986.00K | ▲ 1.13M | ▲ 1.33M | ▼ 1.31M |
Depreciation And Amortization | 432.00K | ▲ 898.00K | ▼ 768.00K | ▲ 773.00K | ▲ 2.36M | ▼ 279.00K | ▲ 334.00K |
Ebitda | -18.18M | ▼ -19.27M | ▼ -28.40M | ▲ -24.62M | ▼ -33.63M | ▲ -26.73M | ▼ -30.59M |
Ebitda Ratio | -20.35 | ▼ -37.94 | ▲ -4.98 | ▲ -3.16 | ▲ 6.15 | ▼ -69.24 | ▲ 0.00 |
Operating Income | -18.61M | ▼ -20.17M | ▼ -29.22M | ▲ -25.42M | ▼ -36.00M | ▲ -27.01M | ▼ -30.92M |
Operating Income Ratio | -20.84 | ▼ -39.70 | ▲ -5.13 | ▲ -3.26 | ▲ 6.58 | ▼ -69.96 | ▲ 0.00 |
Total Other Income Expenses Net | 575.00K | ▼ 441.00K | ▲ 455.00K | ▲ 2.57M | ▲ 31.22M | ▼ -37.38M | ▲ 27.21M |
Income Before Tax | -18.03M | ▼ -19.73M | ▼ -30.13M | ▲ -23.81M | ▲ -4.77M | ▼ -64.38M | ▲ -3.71M |
Income Before Tax Ratio | -20.19 | ▼ -38.84 | ▲ -5.29 | ▲ -3.05 | ▲ 0.87 | ▼ -100.00 | ▲ 0.00 |
Income Tax Expense | 0.00 | 0.00 | ▲ 1.42M | ▼ 986.00K | ▼ -32.35M | ▲ 10.88M | ▼ 0.00 |
Net Income | -18.03M | ▼ -19.73M | ▼ -30.13M | ▲ -23.81M | ▲ 27.58M | ▼ -64.38M | ▲ -3.71M |
Net Income Ratio | -20.19 | ▼ -38.84 | ▲ -5.29 | ▲ -3.05 | ▼ -5.04 | ▼ -100.00 | ▲ 0.00 |
Eps | -5.34 | ▲ -4.49 | ▼ -4.91 | ▲ -3.78 | ▲ 0.99 | ▼ -2.18 | ▲ -0.10 |
Eps Diluted | -5.34 | ▲ -4.49 | ▼ -4.91 | ▲ -3.78 | ▲ 0.99 | ▼ -2.18 | ▲ -0.10 |
Weighted Average Shs Out | 3.37M | ▲ 4.29M | ▲ 6.14M | ▲ 6.29M | ▲ 27.75M | ▲ 29.54M | ▲ 38.98M |
Weighted Average Shs Out Dil | 3.38M | ▲ 4.39M | ▲ 6.14M | ▲ 6.29M | ▲ 27.75M | ▲ 29.54M | ▲ 38.98M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 49.89M | ▼ 41.44M | ▲ 173.98M | ▼ 92.30M | ▲ 167.47M | ▼ 139.53M | ▼ 83.52M |
Short Term Investments | 49.79M | ▲ 49.98M | ▼ 0.00 | ▲ 38.07M | ▼ 34.84M | ▼ 0.00 | ▲ 24.78M |
Cash And Short Term Investments | 99.68M | ▼ 91.42M | ▲ 173.98M | ▼ 130.37M | ▲ 202.30M | ▼ 139.53M | ▼ 108.30M |
Net Receivables | 0.00 | ▲ 20.16M | ▼ 2.33M | ▲ 2.98M | ▼ 1.69M | ▼ 0.00 | 0.00 |
Inventory | 0.00 | ▲ 290.00K | ▼ 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 | 0.00 |
Other Current Assets | 1.42M | ▲ 2.65M | ▼ 2.24M | ▲ 3.24M | ▲ 7.39M | ▼ 5.45M | ▼ 3.90M |
Total Current Assets | 101.73M | ▲ 114.51M | ▲ 178.56M | ▼ 136.59M | ▲ 211.39M | ▼ 144.98M | ▼ 112.20M |
Property Plant Equipment Net | 3.86M | ▲ 31.89M | ▼ 29.64M | ▼ 27.29M | ▼ 24.66M | ▼ 19.48M | ▼ 18.86M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | ▲ 13.04M | ▼ 3.09M | ▼ 2.12M | 2.12M |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 1.17M | ▲ 3.58M | ▲ 5.05M | ▲ 6.03M | ▼ 5.35M | ▼ 1.59M | ▼ 1.55M |
Total Non Current Assets | 5.03M | ▲ 35.47M | ▼ 34.69M | ▲ 46.35M | ▼ 33.09M | ▼ 23.19M | ▼ 22.53M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 106.77M | ▲ 149.98M | ▲ 213.25M | ▼ 182.94M | ▲ 244.49M | ▼ 168.17M | ▼ 134.73M |
Account Payables | 3.31M | ▲ 5.85M | ▼ 3.60M | ▲ 3.69M | ▲ 6.41M | ▲ 11.54M | ▼ 11.35M |
Short Term Debt | 9.00K | ▲ 1.28M | ▲ 1.73M | ▲ 2.01M | ▲ 2.07M | ▲ 8.99M | ▲ 14.08M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 1.93M | ▲ 5.74M | ▲ 12.21M | ▼ 10.18M | ▼ 4.33M | ▼ 0.00 | 0.00 |
Other Current Liabilities | 14.29M | ▼ 10.65M | ▲ 11.08M | ▲ 15.62M | ▲ 17.97M | ▼ 16.15M | ▼ 11.88M |
Total Current Liabilities | 19.53M | ▲ 23.52M | ▲ 28.62M | ▲ 31.51M | ▼ 30.78M | ▲ 36.68M | ▲ 37.30M |
Long Term Debt | 22.00K | ▲ 24.64M | ▲ 64.49M | ▼ 63.18M | ▼ 61.50M | ▼ 34.56M | ▼ 29.71M |
Deferred Revenue Non Current | 8.28M | ▲ 22.64M | ▼ 9.88M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | -22.00K | ▼ -24.64M | ▼ -24.93M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 375.00K | ▲ 24.64M | ▲ 44.65M | ▼ 3.03M | ▲ 24.47M | ▲ 80.28M | ▼ 52.66M |
Total Non Current Liabilities | 8.65M | ▲ 47.28M | ▲ 94.07M | ▼ 66.21M | ▲ 85.97M | ▲ 114.83M | ▼ 82.37M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 31.00K | ▲ 25.92M | ▲ 26.66M | ▼ 24.93M | ▼ 22.92M | ▼ 18.53M | ▼ 17.89M |
Total Liabilities | 28.18M | ▲ 70.79M | ▲ 122.70M | ▼ 97.72M | ▲ 116.75M | ▲ 151.51M | ▼ 119.67M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 34.00K | ▲ 43.00K | ▲ 56.00K | ▲ 61.00K | ▼ 20.00K | ▲ 26.00K | 26.00K |
Retained Earnings | -217.55M | ▼ -292.98M | ▼ -377.02M | ▼ -463.58M | ▼ -558.23M | ▼ -722.81M | ▼ -726.52M |
Accumulated Other Comprehensive Income Loss | -3.00K | ▲ 24.00K | ▼ 0.00 | ▼ -79.00K | ▲ 102.00K | ▼ 0.00 | 0.00 |
Other Total Stockholders Equity | 296.10M | ▲ 372.10M | ▲ 467.52M | ▲ 548.82M | ▲ 685.85M | ▲ 739.44M | ▲ 741.55M |
Total Stockholders Equity | 78.59M | ▲ 79.18M | ▲ 90.55M | ▼ 85.22M | ▲ 127.74M | ▼ 16.66M | ▼ 15.06M |
Total Equity | 78.59M | ▲ 79.18M | ▲ 90.55M | ▼ 85.22M | ▲ 127.74M | ▼ 16.66M | ▼ 15.06M |
Total Liabilities And Stockholders Equity | 106.77M | ▲ 149.98M | ▲ 213.25M | ▼ 182.94M | ▲ 244.49M | ▼ 168.17M | ▼ 134.73M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 106.77M | ▲ 149.98M | ▲ 213.25M | ▼ 182.94M | ▲ 244.49M | ▼ 168.17M | ▼ 134.73M |
Total Investments | 49.79M | ▲ 49.98M | ▼ 0.00 | ▲ 51.11M | ▼ 34.84M | ▼ 2.12M | ▲ 26.90M |
Total Debt | 31.00K | ▲ 25.92M | ▲ 66.21M | ▼ 65.19M | ▼ 63.57M | ▼ 62.08M | ▼ 61.67M |
Net Debt | -49.86M | ▲ -15.52M | ▼ -107.77M | ▲ -27.11M | ▼ -103.90M | ▲ -77.45M | ▲ -21.85M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -18.03M | ▼ -19.73M | ▼ -30.13M | ▲ -23.81M | ▲ -4.77M | ▼ -64.38M | ▲ -3.71M |
Depreciation And Amortization | 432.00K | ▲ 898.00K | ▼ 768.00K | ▲ 773.00K | ▼ 770.00K | ▼ 279.00K | ▲ 334.00K |
Deferred Income Tax | 0.00 | 0.00 | ▲ 375.00K | ▼ -2.46M | ▲ 0.00 | ▲ 8.08M | ▼ 0.00 |
Stock Based Compensation | 1.63M | ▲ 3.22M | ▼ 3.03M | ▼ 2.88M | ▲ 2.90M | ▼ 1.72M | ▲ 2.10M |
Change In Working Capital | 2.46M | ▼ -1.83M | ▼ -4.06M | ▲ -526.00K | ▲ 594.00K | ▲ 6.26M | ▼ -2.86M |
Accounts Receivables | 0.00 | ▼ -20.16M | ▲ -5.00K | ▲ 0.00 | ▲ 77.00K | ▲ 1.67M | ▼ 0.00 |
Inventory | 0.00 | ▼ -928.00K | ▲ 586.00K | ▼ 0.00 | ▼ -77.00K | ▲ 29.00K | ▼ 0.00 |
Accounts Payables | 519.00K | ▲ 1.40M | ▼ -1.16M | ▲ -286.00K | ▲ 2.44M | ▲ 8.69M | ▼ -198.00K |
Other Working Capital | 1.94M | ▲ 17.85M | ▼ -3.48M | ▲ -240.00K | ▼ -1.85M | ▼ -4.10M | ▲ -2.67M |
Other Non Cash Items | -308.00K | ▲ 6.84M | ▼ 91.00K | ▲ 185.00K | ▼ -30.58M | ▲ 29.49M | ▼ -23.99M |
Net Cash Provided By Operating Activities | -13.81M | ▲ -10.60M | ▼ -29.92M | ▲ -22.97M | ▼ -31.08M | ▲ -18.57M | ▼ -31.10M |
Investments In Property Plant And Equipment | -195.00K | ▼ -8.16M | ▲ -29.00K | ▼ -245.00K | ▼ -674.00K | ▲ -38.00K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.56M | ▼ 29.00K |
Purchases Of Investments | -24.77M | ▲ 0.00 | 0.00 | ▼ -34.42M | ▲ 0.00 | 0.00 | ▼ -24.67M |
Sales Maturities Of Investments | 45.00M | ▼ 25.00M | ▼ -50.00M | ▲ 0.00 | ▲ 38.40M | ▼ 0.00 | 0.00 |
Other Investing Activities | 0.00 | ▲ 110.00K | ▲ 50.00M | ▼ 34.42M | ▲ 38.40M | ▼ 1.56M | ▼ 29.00K |
Net Cash Used For Investing Activities | 20.04M | ▼ 16.95M | ▼ -29.00K | ▼ -245.00K | ▲ 37.72M | ▼ 1.52M | ▼ -24.64M |
Debt Repayment | -2.00K | ▼ -56.00K | ▲ 19.86M | ▼ -69.00K | ▼ -75.00K | ▲ -3.00K | ▼ -265.00K |
Common Stock Issued | 0.00 | ▲ 824.00K | ▼ 0.00 | 0.00 | ▼ -8.33M | ▲ 43.38M | ▼ 0.00 |
Common Stock Repurchased | 0.00 | ▲ 161.00K | ▼ 0.00 | 0.00 | ▲ 217.00K | ▲ 257.00K | ▼ 0.00 |
Dividends Paid | 0.00 | ▼ -161.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 139.00K | ▲ 321.00K | ▲ 90.95M | ▼ 165.00K | ▼ -2.51M | ▲ 43.38M | ▼ -265.00K |
Net Cash Used Provided By Financing Activities | 137.00K | ▲ 1.09M | ▲ 110.80M | ▼ 96.00K | ▼ -10.70M | ▲ 43.38M | ▼ -265.00K |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 967.00K | ▼ 0.00 |
Net Change In Cash | 6.36M | ▲ 7.44M | ▲ 80.85M | ▼ -23.12M | ▲ -4.07M | ▲ 27.31M | ▼ -56.00M |
Cash At End Of Period | 50.81M | ▼ 44.82M | ▲ 177.07M | ▼ 95.39M | ▲ 170.55M | ▼ 139.53M | ▼ 83.52M |
Cash At Beginning Of Period | 44.45M | ▼ 37.38M | ▲ 96.22M | ▲ 118.51M | ▲ 174.62M | ▼ 112.22M | ▲ 139.53M |
Operating Cash Flow | -13.81M | ▲ -10.60M | ▼ -29.92M | ▲ -22.97M | ▼ -31.08M | ▲ -18.57M | ▼ -31.10M |
Capital Expenditure | -195.00K | ▼ -8.16M | ▲ -29.00K | ▼ -245.00K | ▼ -674.00K | ▲ -38.00K | ▲ 0.00 |
Free Cash Flow | -14.01M | ▼ -18.76M | ▼ -29.95M | ▲ -23.21M | ▼ -31.76M | ▲ -18.60M | ▼ -31.10M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)